(Q34379799)

1 August 2017

title

Hepatitis B and C and renal failure (English)

1 reference

1 August 2017

1 reference

Zacks SL

1

1 reference

1 August 2017

Fried MW

series ordinal

2

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Infectious Disease Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

877-899

1 reference

Hepatitis B surface antigenemia in a chronic hemodialysis program: lack of influence on morbidity and mortality

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

The long-term outcome of hepatitis B infection in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Recombinant hepatitis B vaccine use in chronic hemodialysis patients. Long-term evaluation and cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis B vaccines in patients with chronic renal failure before dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Impact of hepatitis B and C virus on kidney transplantation outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Treatment of chronic hepatitis B with lamivudine in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis C Infection Among Dialysis Patients: A Comparison Between Patients on Maintenance Haemodialysis and Continuous Ambulatory Peritoneal Dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Liver disease in dialysis patients with antibodies to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Incidence and features of liver disease in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis C virus in dialysis units: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis C in hospital employees with needlestick injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis C virus infection in haemodialysis patients: lessons from epidemiology and prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

The Particle Size Of Hepatitis C Virus Estimated By Filtration Through Microporous Regenerated Cellulose Fibre

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis C virus: the nephrologist's view

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Risk of death among chronic dialysis patients infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Chronic non-A, non-B hepatitis complicated by end-stage renal failure treated with recombinant interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Interferon treatment for chronic hepatitis C in haemodialysis patients: suggestions based on a small series

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Treatment of chronic hepatitis C with interferon alpha in patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Limited benefits of INF-alpha therapy in renal graft candidates with chronic viral hepatitis B or C.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis C infection and post-transplantation liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Anti-HCV antibody is sensitive but not sufficient to detect HCV active infection in renal transplanted patients: the role of PCR for HCV-RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Epidemiology of HCV infection: disease and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis C virus infection and disease in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Depletion of hepatitis C virus from procured kidneys using pulsatile perfusion preservation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis C infection in renal transplant patients: new insights and unanswered questions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Comparison of isolated infection by hepatitis C (HCV) or by hepatitis B (HBV) viruses and of coinfection by HCV-HBV in 1098 renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Superinfection with hepatitis C virus in hemodialysis patients with hepatitis B surface antigenemia: its prevalence and clinical significance in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis C virus infection in dialysis and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis C after renal transplantation: histopathological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Clear evidence of the existence of healthy carriers of hepatitis C virus among renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Detection of antibody to hepatitis C virus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

A prospective study of hepatitis C virus infection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Implications of chronic hepatitis B or hepatitis C infection for renal transplant candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Hepatitis C virus infection among kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

HCV liver disease in renal transplantation: a clinical and histological study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Glomerular disease during HCV infection in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Chronic hepatitis C after renal transplantation. Treatment with alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Interferon treatment for chronic hepatitis C virus infection in uremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Long-term outcome of recombinant INF-alpha treatment of chronic hepatitis C in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Efficacy of interferon alpha in acute hepatitis C in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Interferon treatment of chronic active hepatitis C in patients with end-stage chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

Interferon-alpha treatment of haemodialysis patients with chronic viral hepatitis and its impact on kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970177-X

7 January 2021

10.1016/S0891-5520(05)70177-X

Identifiers

DOI

1 reference

1 August 2017

1 reference